Rituximab Shows Long-Term Benefits in Follicular Lymphoma ...Middle East

News by : (Medscape) -
Long-term results of a phase 3 trial show that early rituximab monotherapy significantly delays the need for new treatment in patients with asymptomatic, low tumour burden follicular lymphoma. Medscape News UK

Read More Details
Finally We wish PressBee provided you with enough information of ( Rituximab Shows Long-Term Benefits in Follicular Lymphoma )

Also on site :

Most Viewed News
جديد الاخبار